First published Monday 29 January 2024.
To give you the best experience, this site uses cookies. Learn more about cookies
Diabetes researchers from Telethon Kids Institute and Perth Children’s Hospital are excited to be taking part in the national Insulin and Abatacept (IAA) trial in type 1 diabetes.
IAA is a randomised controlled trial testing whether the combination of two safe disease-modifying therapies called abatacept and nasal insulin slows down the immune attack on the insulin-producing (beta) cells of people with newly-diagnosed type 1 diabetes. Abatacept is a disease-modifying medication approved for treatment of rheumatoid arthritis in both adults and children.
They are looking for participants aged 6 – 21years old to be involved in the study and must;
To find out more information, visit https://atic.svi.edu.au/clinical-trials/
If you are interested in taking part in this study and would like more information, please contact Alison Roberts at Alison.Roberts@health.wa.gov.au.
First published Monday 29 January 2024.